These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24305949)

  • 1. Cellular maintenance of nuclear protein homeostasis.
    Gallagher PS; Oeser ML; Abraham AC; Kaganovich D; Gardner RG
    Cell Mol Life Sci; 2014 May; 71(10):1865-79. PubMed ID: 24305949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control.
    Samant RS; Livingston CM; Sontag EM; Frydman J
    Nature; 2018 Nov; 563(7731):407-411. PubMed ID: 30429547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposed hydrophobicity is a key determinant of nuclear quality control degradation.
    Fredrickson EK; Rosenbaum JC; Locke MN; Milac TI; Gardner RG
    Mol Biol Cell; 2011 Jul; 22(13):2384-95. PubMed ID: 21551067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How a disordered ubiquitin ligase maintains order in nuclear protein homeostasis.
    Rosenbaum JC; Gardner RG
    Nucleus; 2011; 2(4):264-70. PubMed ID: 21941105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Quality Control Degradation in the Nucleus.
    Enam C; Geffen Y; Ravid T; Gardner RG
    Annu Rev Biochem; 2018 Jun; 87():725-749. PubMed ID: 29925261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Ubiquitin-Proteasome Pathways in Proteostasis Maintenance.
    Franić D; Zubčić K; Boban M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33406777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of Ssa1/Ssa2 Hsp70 chaperone involvement in nuclear protein quality control degradation varies with the substrate.
    Jones RD; Enam C; Ibarra R; Borror HR; Mostoller KE; Fredrickson EK; Lin J; Chuang E; March Z; Shorter J; Ravid T; Kleiger G; Gardner RG
    Mol Biol Cell; 2020 Feb; 31(3):221-233. PubMed ID: 31825716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of molecular chaperone in protein-misfolding brain diseases.
    Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
    Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
    Di Domenico F; Lanzillotta C
    Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteostasis in neurodegenerative diseases.
    Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
    Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.
    Kriegenburg F; Ellgaard L; Hartmann-Petersen R
    FEBS J; 2012 Feb; 279(4):532-42. PubMed ID: 22177318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear proteasome and the degradation of oxidatively damaged proteins.
    Voss P; Grune T
    Amino Acids; 2007; 32(4):527-34. PubMed ID: 17103119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-dependent and independent roles of SUMO in proteostasis.
    Liebelt F; Vertegaal AC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C284-96. PubMed ID: 27335169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chaperones in Parkinson's disease and prion diseases.
    Winklhofer KF; Tatzelt J
    Handb Exp Pharmacol; 2006; (172):221-58. PubMed ID: 16610362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
    Huang Q; Figueiredo-Pereira ME
    Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control of the proteins associated with neurodegenerative diseases.
    Gao X; Hu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein quality control in the nucleus.
    Nielsen SV; Poulsen EG; Rebula CA; Hartmann-Petersen R
    Biomolecules; 2014 Jul; 4(3):646-61. PubMed ID: 25010148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear protein quality is regulated by the ubiquitin-proteasome system through the activity of Ubc4 and San1 in fission yeast.
    Matsuo Y; Kishimoto H; Tanae K; Kitamura K; Katayama S; Kawamukai M
    J Biol Chem; 2011 Apr; 286(15):13775-90. PubMed ID: 21324894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.